CRL vs TCBX · rev $2.00B vs P/E 10, rev $354.0M
Charles River Laboratories (CRL) versus Third Coast Bancshares, Inc. (TCBX) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Third Coast Bancshares, Inc. (TCBX) is a banks - regional company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported TCBX revenue for 2025-12-31 was $354.0M. Net income was $66.3M. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. TCBX currently screens at market cap $661.7M and trailing P/E 10.3.
CRL currently screens at market cap $7.78B. TCBX currently screens at market cap $661.7M and trailing P/E 10.3.
Not investment advice. Open the CRL and TCBX stock pages for the full models.
Not investment advice.